Company Filing History:
Years Active: 2019-2024
Title: Laura Akullian D'Agostino: Innovator in Pharmaceutical Science
Introduction
Laura Akullian D'Agostino is a prominent inventor based in Sudbury, MA (US). She has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative compounds and methods for treating diseases.
Latest Patents
D'Agostino holds two patents that showcase her expertise. The first patent involves inhibitors of protein tyrosine phosphatase, specifically targeting PTPN2. This invention includes compounds that are useful in treating cancer and diseases susceptible to PTPN2 inhibition. The second patent focuses on biomolecule conjugates that incorporate non-natural amino acids, which serve as attachment points for cytotoxic agents. This invention aims to enhance the efficacy of cell-binding agents and active release products.
Career Highlights
Throughout her career, D'Agostino has worked with notable companies such as Celgene Corporation and Bristol-Myers Squibb Company. Her work in these organizations has contributed to advancements in drug development and therapeutic applications.
Collaborations
D'Agostino has collaborated with esteemed colleagues, including Eric Schwartz and Hernan Cuervo. These partnerships have fostered innovation and the exchange of ideas in the pharmaceutical industry.
Conclusion
Laura Akullian D'Agostino is a distinguished inventor whose work has significantly impacted the field of pharmaceutical science. Her patents and collaborations reflect her commitment to advancing medical treatments and improving patient outcomes.